| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.029 | 0.6 |